279 related articles for article (PubMed ID: 15613103)
1. Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels.
Glenjen NI; Hatfield K; Bruserud Ø
Eur J Haematol; 2005 Jan; 74(1):24-34. PubMed ID: 15613103
[TBL] [Abstract][Full Text] [Related]
2. Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts.
Bruserud Ø; Ryningen A; Wergeland L; Glenjen NI; Gjertsen BT
Haematologica; 2004 Apr; 89(4):391-402. PubMed ID: 15075072
[TBL] [Abstract][Full Text] [Related]
3. In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8.
Ryningen A; Wergeland L; Glenjen N; Gjertsen BT; Bruserud O
Leuk Res; 2005 Feb; 29(2):185-96. PubMed ID: 15607368
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of native human acute myelogenous leukemia blasts on fibroblasts and osteoblasts.
Glenjen N; Ersvaer E; Ryningen A; Bruserud Ø
Int J Cancer; 2004 Oct; 111(6):858-67. PubMed ID: 15300797
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
6. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
[TBL] [Abstract][Full Text] [Related]
7. Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release.
Reikvam H; Hatfield KJ; Lassalle P; Kittang AO; Ersvaer E; Bruserud Ø
Expert Opin Investig Drugs; 2010 Feb; 19(2):169-83. PubMed ID: 20050812
[TBL] [Abstract][Full Text] [Related]
8. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
10. [Expression of vascular endothelial growth factor in bone marrow cells of patients with acute myeloid leukemia].
Xu D; Meng FY; Zhang Y
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):357-9. PubMed ID: 12422902
[TBL] [Abstract][Full Text] [Related]
11. Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia.
de Jonge HJ; Weidenaar AC; Ter Elst A; Boezen HM; Scherpen FJ; Bouma-Ter Steege JC; Kaspers GJ; Goemans BF; Creutzig U; Zimmermann M; Kamps WA; de Bont ES
Clin Cancer Res; 2008 Feb; 14(3):924-30. PubMed ID: 18245556
[TBL] [Abstract][Full Text] [Related]
12. Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells.
Böhm A; Aichberger KJ; Mayerhofer M; Herrmann H; Florian S; Krauth MT; Derdak S; Samorapoompichit P; Sonneck K; Vales A; Gleixner KV; Pickl WF; Sperr WR; Valent P
Eur J Clin Invest; 2009 May; 39(5):395-405. PubMed ID: 19320940
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
14. [Expression of angiogenic factors and their clinical significances in acute myeloid leukemia].
Wang Y; Xiao ZJ; Liu P; Peng Z; Han ZC
Ai Zheng; 2004 Nov; 23(11 Suppl):1423-7. PubMed ID: 15566649
[TBL] [Abstract][Full Text] [Related]
15. [Change of vascular endothelial growth factor and its receptors expression in acute myeloid leukemia before and after treatment].
Zhang JQ; Wang JK; Li YM
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):100-2. PubMed ID: 14990052
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells.
Clarkin CE; Emery RJ; Pitsillides AA; Wheeler-Jones CP
J Cell Physiol; 2008 Feb; 214(2):537-44. PubMed ID: 17685428
[TBL] [Abstract][Full Text] [Related]
17. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.
Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF
Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634
[TBL] [Abstract][Full Text] [Related]
18. Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blasts.
Bruserud Ø; Wendelbo Ø; Paulsen K
Eur J Haematol; 2004 Nov; 73(5):340-50. PubMed ID: 15458513
[TBL] [Abstract][Full Text] [Related]
19. [Expression of vascular endothelial growth factor and its receptors KDR and Flt1 in acute myeloid leukemia].
Wang Y; Xiao ZJ; Liu P; Yang C; Yang RC; Cai YL; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):249-52. PubMed ID: 12859876
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
Köhler T; Plettig R; Wetzstein W; Schmitz M; Ritter M; Mohr B; Schaekel U; Ehninger G; Bornhäuser M
Stem Cells; 2000; 18(2):139-47. PubMed ID: 10742386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
